This review highlights the mechanistic role of the intrarenal renin-angiotensin system in diabetic nephropathy and proposes urinary angiotensinogen as an early biomarker of its activity.
No takes yet. Share an insight, caveat, or question.
Supports intrarenal RAS in diabetic nephropathy; hypothesis-generating for urinary angiotensinogen as biomarker pending validation.
Kobori et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: